Vertex Pharmaceuticals Inc / Ma

Hardman Johnston Global Advisors LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/23/2026

Shares

63,806

Value ($000)

28,927

Weight

1.4%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/23/2026	28,927	1.4%	63,806	12/31/2025
2025 Q3	10/27/2025	30,999	1.5%	79,152	9/30/2025
2025 Q2	7/21/2025	48,182	2.1%	108,225	6/30/2025